WAYFIND-R is a registry that aims to capture high-quality real-world data linking next-generation sequencing, treatments and outcomes from cancer patients diagnosed with a solid tumour. The WAYFIND-R has three main overarching objectives: 1. To provide a platform to support the design and conduct of clinical and epidemiological research; 2. To develop an evidence-generation platform to better understand health outcomes and cancer care processes; and 3. To characterize the treatments and clinical course of solid tumor cancers in patients who have undergone NGS testing.
Study Type
OBSERVATIONAL
Enrollment
7,864
Overall Survival
Time frame: From date of registry entry until death, for up to 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Instituto Alexander Fleming
Buenos Aires, Argentina
CEMIC
Buenos Aires, Argentina
Lkh-Univ. Klinikum Graz
Graz, Austria
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Instituto do Cancer do Estado de Sao Paulo - ICESP
São Paulo, São Paulo, Brazil
Hospital Alemao Oswaldo Cruz
São Paulo, São Paulo, Brazil
D'or Instituto de Pesquisa e Educação
Rio de Janeiro, Brazil
Beneficencia Portuguesa de Sao Paulo
São Paulo, Brazil
Alberta Health Services
Calgary, Alberta, Canada
The Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
...and 126 more locations